Literature DB >> 27866493

Dietary DHA and health: cognitive function ageing.

Carlos Cardoso1, Cláudia Afonso1, Narcisa M Bandarra1.   

Abstract

DHA is a key nutritional n-3 PUFA and needs to be supplied by the human diet. DHA is found in significant amounts in the retinal and neuronal cell membranes due to its high fluidity. Indeed, DHA is selectively concentrated in the synaptic and retinal membranes. DHA is deemed to display anti-inflammatory properties and to reduce the risk of CVD. Consumption of larger amounts of DHA appears to reduce the risk of depression, bipolar disorder, schizophrenia and mood disorders. Conversely, it has been shown that loss of DHA from the nerve cell membrane leads to dysfunction of the central nervous system in the form of anxiety, irritability, susceptibility to stress, dyslexia, impaired memory and cognitive functions, and extended reaction times. DHA plays an important role in ensuring a healthy ageing, by thwarting macular degeneration, Alzheimer's disease, and other brain disorders at the same time as enhancing memory and strengthening neuroprotection in general. A reduced level of DHA is associated with cognitive decline during ageing. Different mechanisms for this fundamental DHA role have been put forward. Namely, neuroprotectin D1, a DHA derivative, may support brain cell survival and repair through neurotrophic, anti-apoptotic, and anti-inflammatory signalling. Many of the effects of DHA on the neurological system may be related to signalling connections, thus leading to the study of the related signalolipidomics. Therefore, the present review will focus on the influence of DHA deficiency upon ageing, with specific emphasis upon neurological disorders related to cognitive function and mental health.

Entities:  

Keywords:  AD Alzheimer’s disease; ALA α-linolenic acid; FA fatty acid; MCI mild cognitive impairment; NPD1 neuroprotectin D1; NeuroPs neuroprostanes; PC phosphatidylcholine; PL phospholipid; RCT randomised controlled trial; RDI recommended daily intake; β-APP β-amyloid precursor protein; Ageing; Cognitive disorders; DHA; Marine sources; Mental health

Mesh:

Substances:

Year:  2016        PMID: 27866493     DOI: 10.1017/S0954422416000184

Source DB:  PubMed          Journal:  Nutr Res Rev        ISSN: 0954-4224            Impact factor:   7.800


  38 in total

1.  Metabolomics activity screening for identifying metabolites that modulate phenotype.

Authors:  Carlos Guijas; J Rafael Montenegro-Burke; Benedikt Warth; Mary E Spilker; Gary Siuzdak
Journal:  Nat Biotechnol       Date:  2018-04-05       Impact factor: 54.908

2.  Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain.

Authors:  Regina F Fernandez; Sora Q Kim; Yingwei Zhao; Rachel M Foguth; Marcus M Weera; Jessica L Counihan; Daniel K Nomura; Julia A Chester; Jason R Cannon; Jessica M Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-06       Impact factor: 11.205

Review 3.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

4.  Docosahexaenoic acid supplementation in age-related cognitive decline: a systematic review and meta-analysis.

Authors:  Rakesh Balachandar; Soundarya Soundararajan; Bhavani Shankara Bagepally
Journal:  Eur J Clin Pharmacol       Date:  2020-02-14       Impact factor: 2.953

5.  Effects of docosahexaenoic acid on locomotor activity in ethanol-treated HIV-1 transgenic rats.

Authors:  Jianlin He; Wenfei Huang; Shizhong Zheng; Michael Vigorito; Sulie L Chang
Journal:  J Neurovirol       Date:  2017-12-19       Impact factor: 2.643

6.  Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial.

Authors:  Mengyue Li; Wen Li; Yiming Gao; Yongjie Chen; Dong Bai; Jinxi Weng; Yue Du; Fei Ma; Xinyan Wang; Huan Liu; Guowei Huang
Journal:  Eur J Nutr       Date:  2020-08-28       Impact factor: 5.614

Review 7.  Acyl-CoA synthetases as regulators of brain phospholipid acyl-chain diversity.

Authors:  Regina F Fernandez; Jessica M Ellis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-15       Impact factor: 4.006

8.  The Relationship Between Mild Cognitive Impairment and Anti-Inflammatory/Pro-Inflammatory Nutrients in the Elderly in Northern China: A Bayesian Kernel Machine Regression Approach.

Authors:  Ruiqiang Li; Wenqiang Zhan; Xin Huang; Limin Zhang; Zechen Zhang; Meiqi Zhou; Zhihong Wang; Yuxia Ma
Journal:  J Inflamm Res       Date:  2022-01-14

9.  Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain.

Authors:  Pengbo Guo; Mengjie Si; Di Wu; Hui Yi Xue; Wenhui Hu; Ho Lun Wong
Journal:  J Control Release       Date:  2020-10-01       Impact factor: 9.776

10.  Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging.

Authors:  Regina F Fernandez; Andrea S Pereyra; Victoria Diaz; Emily S Wilson; Karen A Litwa; Jonatan Martínez-Gardeazabal; Shelley N Jackson; J Thomas Brenna; Brian P Hermann; Jeffrey B Eells; Jessica M Ellis
Journal:  JCI Insight       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.